All eyes are on Spectral Medical, as it issues
a groundbreaking press release that has everyone gasping for more and their Stockhouse pumpers disagreeing whether the SP is in a better position at 20 or 40 cents. Next week might prove even better, when the company is expected to announce it still exists, amidst the speculation it could be bought at its current market price by a pharmaceutical giant, that seems to have no particular feelings for its retail shareholders. All this as some pretend entrepreneurs are raging that the famed investment bullboard is frequented by people who are not ready to put in the effort to praise the assests the company is so willing to let erode in the wind.